Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients

NCT02473731 is registered in ClinicalTrials.gov with Celldex Therapeutics as lead sponsor.

NCT NCT02473731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02473731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Window of Opportunity Study of KTN3379 in Surgically Resectable Head and Neck Cancer Patients
Lead sponsor
Celldex Therapeutics
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2015
Completion date
October 10, 2016
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of the head and neck